Clinical Trials Directory

Trials / Completed

CompletedNCT05061797

A Study to Examine the Effect of a Thermogenic Energy Drink in Healthy Adults

A Double-Blind, Randomized, Crossover Study to Examine the Thermogenic Effect of an Energy Drink in Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Rowdy Energy · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study is intended to examine the acute thermogenic effects of the active study product (energy drink), in healthy adults.

Detailed description

The active study product and a control will be blinded with 3 digit codes. Human subjects will consume the coded products in a randomized manner. Measurements of rest energy expenditure via respiration will be performed throughout a 3 hour time span with controlled intervention an observation. Additional metrics will be gathered relating to benefits and/or side effects. The data gathered will be used to calculate the thermogenic impact of the active study product on healthy adults. The study is designed based on statistical confidence, with a minimum required number of active participants set to 26. 30 participants will be recruited.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTThermogenic Energy Drink - Active Study Product FormulaThe Thermogenic Energy Drink is the Active Study Product (ASP). This energy drink formula combines, caffeine, guarana, Vitamins C, B3, B6, B12, Magnesium, Potassium, L-Citrulline, L-Arginine HCl, L-Glutamine, and Chlorogenic Acids from green coffee bean extract. Participants will consume an assigned amount of the beverage (355 ml), under observation. They will be monitored for the following 180 minutes with measurements of respiration for Resting Energy Expenditure (RER) and other metabolic markers as well as satiety via Visual Analog Scale (VAS).
DIETARY_SUPPLEMENTPlaceboA carbonated soft drink with the same appearance, flavor and aroma as the active study product. Study participants will consume an assigned amount of the beverage (355 ml) under observation. They will then be monitored for the subsequent 180 minutes with measurements for respiration for Resting Energy Expenditure (RER) and other metabolic markers as well as satiety via a Visual Analog Scale (VAS).

Timeline

Start date
2021-08-23
Primary completion
2021-10-11
Completion
2021-11-16
First posted
2021-09-30
Last updated
2022-05-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05061797. Inclusion in this directory is not an endorsement.